PEPGEN INC. Shares Outstanding (Cover Page)
PEPGEN INC. (PEPG) had Shares Outstanding (Cover Page) of 69.26 million shares as of 2026-08-02, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-02: Entity Common Stock, Shares Outstanding 69.26M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 69.17M shares.
- 2026-02-26: Entity Common Stock, Shares Outstanding 69.12M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 68.75M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-02 | 69.26M shares 10-Q · filed 2026-08-06 |
| 2026-05-06 | 69.17M shares 10-Q · filed 2026-05-12 |
| 2026-02-26 | 69.12M shares 10-K · filed 2026-03-04 |
| 2025-11-05 | 68.75M shares 10-Q · filed 2025-11-12 |
| 2025-08-01 | 32.80M shares 10-Q · filed 2025-08-07 |
| 2025-05-01 | 32.72M shares 10-Q · filed 2025-05-08 |
| 2025-02-18 | 32.69M shares 10-K · filed 2025-02-24 |
| 2024-11-01 | 32.60M shares 10-Q · filed 2024-11-07 |
| 2024-08-01 | 32.59M shares 10-Q · filed 2024-08-08 |
| 2024-05-01 | 32.42M shares 10-Q · filed 2024-05-14 |
| 2024-03-01 | 32.35M shares 10-K/A · filed 2024-03-29 |
| 2023-11-03 | 23.81M shares 10-Q · filed 2023-11-08 |
| 2023-08-01 | 23.81M shares 10-Q · filed 2023-08-08 |
| 2023-04-28 | 23.78M shares 10-Q · filed 2023-05-11 |
| 2023-03-15 | 23.78M shares 10-K · filed 2023-03-23 |
| 2022-11-07 | 23.63M shares 10-Q · filed 2022-11-10 |
| 2022-08-12 | 23.63M shares 10-Q · filed 2022-08-12 |
| 2022-06-16 | 23.63M shares 10-Q · filed 2022-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |